OMS721 100 mg/ml Injection solution, OMS00620646, OMS620646, MASP-2 Antibody ( DrugBank: MASP-2 antibody )


2 diseases
IDDisease name (Link within this page)Number of trials
64Thrombotic thrombocytopenic purpura3
109Atypical hemolytic uremic syndrome3

64. Thrombotic thrombocytopenic purpura


Clinical trials : 92Drugs : 85 - (DrugBank : 21) / Drug target genes : 18 - Drug target pathways : 76 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

109. Atypical hemolytic uremic syndrome


Clinical trials : 114Drugs : 36 - (DrugBank : 7) / Drug target genes : 3 - Drug target pathways : 11 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries